NPPES file of Aug 9, 2026

Matthew Lewis Chase, M.D.

Hematology & Oncology Physician · Honolulu, HI

Matthew Lewis Chase, M.D. is a hematology & oncology physician with a practice address in Honolulu, Hawaii, and NPI 1437562899, issued on Jun 3, 2014. Check the license (Hawaii MD-19142, as entered in NPPES) on the Hawaii Medical Board; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1437562899
Name
Matthew Lewis Chase
Credential
M.D.
Primary taxonomy
Hematology & Oncology Physician 207RH0003X
License number
MD-19142 HI
Self-reported in NPPES; status is on the state search
Practice location
3288 Moanalua RD, Honolulu, HI 96819
Phone
(808) 432-0000
Enumerated
Jun 3, 2014
Record last updated
Mar 6, 2024
Medicare enrollment
Enrolled (PECOS I20170922002675); accepts Medicare assignment
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 3288 Moanalua RD

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Randal Aaberg, MDUrology Physician1588763981
  2. Peter Abcarian, MDVascular & Interventional Radiology Physician1457451155
  3. Melissa Abraham, M.A., CCC-SLPSpeech-Language Pathologist1295064301
  4. Alan Ahana, MDAnesthesiology Physician1376742239
  5. Harrison Aihara, PHARMDPharmacist1124174321
  6. Oluwatoyin Ajose, MDPediatrics Physician1114090008

Verify Matthew Lewis Chase in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersHawaii Medical Board
    Search for license MD-19142
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Hawaii license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

26% fewer Medicare Part D claims than the average hematology & oncology physician in 2024

652 Medicare Part D claims for 121 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 29% of claims. 38 claims were for opioids.

  1. Matthew Chase652
  2. Specialty average877

Most prescribed

  1. Prednisone55 claims
  2. Anastrozole52 claims
  3. Tagrisso49 claims
  4. Xtandi48 claims
  5. Dexamethasone47 claims
  6. Acyclovir31 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Industry payments in 2024: $25.97

1 payment: food and beverage; the largest payer was Abbvie Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Matthew Chase$25.97
  2. Specialty average$7,481.41

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Hawaii Permanente Medical Group IncHonolulu, HI

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Hematology & Oncology Physician providers in Hawaii

There are 49 hematology & oncology physician records in Hawaii.

Other hematology & oncology physician records in Hawaii

  1. Jared Acoba, M.D.Honolulu, HI1508889338
  2. William Adler, M.D.Wailuku, HI1710918610
  3. Devena Alston-Johnson, MDWailuku, HI1891732616
  4. Ramin Altaha, MDWailuku, HI1083649982
  5. Swaty Arora, MDHonolulu, HI1194037432
  6. Keola Beale, M.D.Honolulu, HI1699706622
  7. Jeffrey Berenberg, MDTamc, HI1275523250
  8. Craig Boddy, M.D.Honolulu, HI1265796270
  9. Jennifer Carney, M.D.Honolulu, HI1548370604
  10. Jonathan Cho, M.D.Honolulu, HI1174590541

Common questions

What is Matthew Lewis Chase, M.D.'s NPI number?

Matthew Lewis Chase, M.D.'s National Provider Identifier (NPI) is 1437562899, issued on Jun 3, 2014. An NPI identifies a provider in billing; it is not a license.

Where is Matthew Lewis Chase, M.D. located?

The NPPES record lists a practice address at 3288 Moanalua RD, Honolulu, HI, 96819. Phone: (808) 432-0000. Providers update this record themselves, so call before visiting.

How can I verify Matthew Lewis Chase, M.D.'s license?

NPPES lists Hawaii license number MD-19142, as entered by the provider. Search the Hawaii Medical Board at https://cca.hawaii.gov/pvl/boards/medical/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Matthew Lewis Chase, M.D. prescribe under Medicare Part D?

In 2024, Matthew Lewis Chase, M.D. had 652 Medicare Part D claims for 121 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.